These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11579439)

  • 1. Pharmacokinetics and its role in small molecule drug discovery research.
    Jang GR; Harris RZ; Lau DT
    Med Res Rev; 2001 Sep; 21(5):382-96. PubMed ID: 11579439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics.
    Fan J; de Lannoy IA
    Biochem Pharmacol; 2014 Jan; 87(1):93-120. PubMed ID: 24055064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Bioavailability and Disposition protocol: A novel higher throughput approach to assess pharmacokinetics and steady-state brain distribution with reduced animal usage.
    Fu T; Gao R; Scott-Stevens P; Chen Y; Zhang C; Wang J; Summerfield S; Liu H; Sahi J
    Eur J Pharm Sci; 2018 Sep; 122():13-21. PubMed ID: 29857045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current concepts in pharmacokinetics and their implications for clinical medicine.
    Müller M; Müller-Zellenberg U; Hochhaus G; Derendorf H
    Wien Klin Wochenschr; 2001 Aug; 113(15-16):566-72. PubMed ID: 11571833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
    Lüpfert C; Reichel A
    Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics in Drug Discovery: An Exposure-Centred Approach to Optimising and Predicting Drug Efficacy and Safety.
    Reichel A; Lienau P
    Handb Exp Pharmacol; 2016; 232():235-60. PubMed ID: 26330260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Chimeric Mice with Humanized Liver for Predicting Human Pharmacokinetics in Drug Discovery: Comparison with in Vitro-in Vivo Extrapolation and Allometric Scaling.
    Naritomi Y; Sanoh S; Ohta S
    Biol Pharm Bull; 2019; 42(3):327-336. PubMed ID: 30828063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear pharmacokinetic parameters for monoclonal antibodies are similar within a species and across different pharmacological targets: A comparison between human, cynomolgus monkey and hFcRn Tg32 transgenic mouse using a population-modeling approach.
    Betts A; Keunecke A; van Steeg TJ; van der Graaf PH; Avery LB; Jones H; Berkhout J
    MAbs; 2018 Jul; 10(5):751-764. PubMed ID: 29634430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allometric scaling for predicting human clearance of bisphenol A.
    Collet SH; Picard-Hagen N; Lacroix MZ; Puel S; Viguié C; Bousquet-Melou A; Toutain PL; Gayrard V
    Toxicol Appl Pharmacol; 2015 May; 284(3):323-9. PubMed ID: 25759244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of human pharmacokinetics of activated recombinant factor VII and B-domain truncated factor VIII from animal population pharmacokinetic models of haemophilia.
    Larsen MS; Juul RV; Groth AV; Simonsson USH; Kristensen AT; Knudsen T; Agersø H; Kreilgaard M
    Eur J Pharm Sci; 2018 Mar; 115():196-203. PubMed ID: 29369801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Clinical Pharmacokinetics, Prediction of Human Pharmacokinetics and First-in-Human Dose Selection for CNTO 5825, an Anti-Interleukin-13 Monoclonal Antibody.
    Nnane IP; Xu Z; Zhou H; Davis HM
    Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):219-25. PubMed ID: 25683750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
    Fabre MA; Fuseau E; Ficheux H
    J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of the anti-interleukin-20 monoclonal antibody NNC0109-0012 in healthy volunteers and patients with psoriasis or rheumatoid arthritis.
    Lundblad MS; Overgaard RV; Göthberg M; Fjording MS; Watson E
    Adv Ther; 2015 Mar; 32(3):228-38. PubMed ID: 25749867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data?
    Caldwell GW; Masucci JA; Yan Z; Hageman W
    Eur J Drug Metab Pharmacokinet; 2004; 29(2):133-43. PubMed ID: 15230342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
    Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a hybrid physiologically based pharmacokinetic model with drug-specific scaling factors in rat to improve prediction of human pharmacokinetics.
    Sayama H; Komura H; Kogayu M; Iwaki M
    J Pharm Sci; 2013 Nov; 102(11):4193-204. PubMed ID: 24018828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of oral pharmacokinetics of cMet kinase inhibitors in humans: physiologically based pharmacokinetic model versus traditional one-compartment model.
    Yamazaki S; Skaptason J; Romero D; Vekich S; Jones HM; Tan W; Wilner KD; Koudriakova T
    Drug Metab Dispos; 2011 Mar; 39(3):383-93. PubMed ID: 21098644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species.
    Riviere JE; Martin-Jimenez T; Sundlof SF; Craigmill AL
    J Vet Pharmacol Ther; 1997 Dec; 20(6):453-63. PubMed ID: 9430769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pk-fit: a pharmacokinetic/pharmacodynamic and statistical data analysis software.
    Farenc C; Fabreguette JR; Bressolle F
    Comput Biomed Res; 2000 Oct; 33(5):315-29. PubMed ID: 11017724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-in-1 dosing pharmacokinetics in drug discovery: experience, theoretical and practical considerations.
    He K; Qian M; Wong H; Bai SA; He B; Brogdon B; Grace JE; Xin B; Wu J; Ren SX; Zeng H; Deng Y; Graden DM; Olah TV; Unger SE; Luettgen JM; Knabb RM; Pinto DJ; Lam PY; Duan J; Wexler RR; Decicco CP; Christ DD; Grossman SJ
    J Pharm Sci; 2008 Jul; 97(7):2568-80. PubMed ID: 17914718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.